trending Market Intelligence /marketintelligence/en/news-insights/trending/xrFvHVv_lEo7fhRMNhG2xA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Australia's Botanix raises A$38.2M from private placement

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Australia's Botanix raises A$38.2M from private placement

Botanix Pharmaceuticals Ltd. raised A$38.2 million in gross proceeds from a private placement of shares against the total commitment of A$40 million by investment funds and institutional investors.

The Perth, Australia-based biotechnology company issued 181,976,191 shares at 21 Australian cents apiece.

The company said it is waiting to receive the remaining A$1.8 million from a U.S. investor and will issue the remaining shares after funds are cleared.

Botanix will use the funds for developing clinical programs and commercialization activities. Proceeds will also be used for general working capital purposes.

Cowen and Co. LLC acted as lead placement agent, while the Australian portion of the placement was jointly managed by Argonaut Securities Pty. Ltd. and Bell Potter Securities Ltd.